|
09:00 - 10:15
|
Human papillomaviruses: Epidemiology (Salle virtuelle AFIPP2021) - 9h00-9h15 Introduction - Christine Clavel (Université de Champagne-Ardennes) |
|
|
09:00 - 09:15
|
Introduction (Salle virtuelle AFIPP2021) - Christine Clavel (Université de Champagne-Ardennes) |
|
|
09:15 - 09:45
|
Current status on vaccine coverage, screening and disease elimination (Salle virtuelle AFIPP2021) - Laia Bruni (Catalan Institute of Oncology, Barcelona) |
|
|
09:45 - 10:15
|
HPV and cancer : epidemiological update and worldwide disease burden (Salle virtuelle AFIPP2021) - Gary Clifford (IARC, Lyon) |
|
|
10:25 - 13:00
|
SENTICOL group: new markers for human papillomavirus infections (Salle virtuelle AFIPP2021) - Ignacio Bravo / Christine Clavel |
|
|
10:30 - 11:00
|
New biomarkers for diagnosis and follow-up of HPV-induced cancers (Salle virtuelle AFIPP2021) - Hélène Péré (HEGP, Paris) |
|
|
11:00 - 11:30
|
NGS technology and data analysis pipeline to analyze HPV integration (Salle virtuelle AFIPP2021) - Syvlain Baulande (Institut Curie, Paris) |
|
|
11:30 - 12:00
|
HPV integration hotspots in the RAIDS study (Salle virtuelle AFIPP2021) - Ivan Bièche et Maud Kamal (Institut Curie, Paris) |
|
|
12:00 - 12:30
|
Circulating tumor DNA in the RAIDS study (Salle virtuelle AFIPP2021) - Emmanuelle Jeannot (Institut Curie, Paris) |
|
|
12:30 - 12:50
|
HPV16 viral load predicts risk of high-grade cervical lesions (Salle virtuelle AFIPP2021) - Jean-Luc Prétet (Université Bourgogne Franche-Comté) |
|
|
15:30 - 16:30
|
Human papillomaviruses/polyomaviruses: genetic evolution and diversity (Salle virtuelle AFIPP2021) - Dorian McIlroy / Antoine Touzé |
|
|
15:30 - 16:00
|
Evolution and classification of HPVs (Salle virtuelle AFIPP2021) - Dr Nacho Bravo (CNRS, Montpellier) |
|
|
16:00 - 16:30
|
Virus Hunting: You can’t always get what you want (HPyVs), but you get HPVs (and more!) (Salle virtuelle AFIPP2021) - Dr Diana Pastrana (National Cancer Institute, NIH, USA) |
|
|
16:40 - 17:45
|
Human papillomaviruses/polyomaviruses: antiviral immunity and vaccination (Salle virtuelle AFIPP2021) - Dorian McIlroy / Antoine Touzé |
|
|
16:40 - 17:10
|
First-in-human clinical trial of an SFV-Based RNA replicon cancer vaccine against HPV-induced cancers (Salle virtuelle AFIPP2021) - Prof. Toos Daemen (University Medical Center Groningen, Pays-Bas) |
|
|
17:15 - 17:45
|
Antibody responses to Papilloma and Polyoma Viruses (Salle virtuelle AFIPP2021) - Dr Denise Galloway (Fred Hutchinson Cancer Research Center, Seattle) |
|
